Case Studies

Advanced analytical methods play a crucial role in identifying emerging contaminants, unexpected adulterants, food contact material migrants, and other unanticipated chemicals that may compromise regulatory compliance and consumer safety for dietary supplements. Read our white paper to learn about suspect screening and non-target analysis workflows.

The FDA’s guidance to control the amount of lactose in food and supplements states lactose must not be present, so manufacturers are dependent upon the level of detection for analytical methods. Eurofins Food Chemistry Testing Madison, Inc. has recently optimized our High-Performance Anion Exchange Chromatography method for low lactose determination to improve upon the accuracy and specificity obtained across a variety of different product types when quantifying at low concentrations.

The current Good Manufacturing Practice (cGMPs) regulations for dietary supplements in the US were implemented in 2007, but there is still a great deal of enforcement activity by FDA. This white paper will provide an overview of the regulations, but more importantly will highlight some of the most commonly cited issues in FDA Form 483 observations.

Manufacturers and marketers of dietary supplements often have questions about what testing is required for Supplement Facts labels. This white paper is intended to provide information to help companies make informed choices about the testing and claims made on dietary supplements.